Haemonetics Corp. Files SEC Form 4, Statement of Changes in Beneficial Ownership of Securities: (Apr. 17, 2024).
In: Medical Devices & Surgical Technology Week, 2024-05-30, S. 2657-2657
serialPeriodical
Zugriff:
Haemonetics Corp., a medical device company, has filed a Form 4 with the U.S. Securities and Exchange Commission (SEC) on April 17, 2024. The company's SIC code is 3841, which corresponds to Surgical and Medical Instruments and Apparatus. The filing contains information about changes in beneficial ownership of securities and is a requirement for directors, officers, and owners of more than ten percent of a class of equity securities. The SEC filing is a formal document or financial statement submitted by publicly-traded companies. For more information, the SEC filing can be accessed through the provided link. [Extracted from the article]
Copyright of Medical Devices & Surgical Technology Week is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Titel: |
Haemonetics Corp. Files SEC Form 4, Statement of Changes in Beneficial Ownership of Securities: (Apr. 17, 2024).
|
---|---|
Zeitschrift: | Medical Devices & Surgical Technology Week, 2024-05-30, S. 2657-2657 |
Veröffentlichung: | 2024 |
Medientyp: | serialPeriodical |
ISSN: | 1537-1409 (print) |
Sonstiges: |
|